Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.
People with cancer not only are at increased risk for severe COVID-19, they also face treatment interruptions due to the pandemic.
Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.
People with blood cancers and those on chemotherapy may not respond adequately to their first two vaccine doses.
A study from the Leukemia & Lymphoma Society finds that antibody production varies widely across blood cancer types.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.